GLORIA-AF Registry Program (Phase I)

CompletedOBSERVATIONAL
Enrollment

1,096

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Atrial Fibrillation
Trial Locations (62)

Unknown

1160.114.08017 Boehringer Ingelheim Investigational Site, Beijing

1160.114.08018 Boehringer Ingelheim Investigational Site, Beijing

1160.114.08019 Boehringer Ingelheim Investigational Site, Beijing

1160.114.08020 Boehringer Ingelheim Investigational Site, Beijing

1160.114.08023 Boehringer Ingelheim Investigational Site, Beijing

1160.114.08024 Boehringer Ingelheim Investigational Site, Beijing

1160.114.08025 Boehringer Ingelheim Investigational Site, Beijing

1160.114.08007 Boehringer Ingelheim Investigational Site, Changsha

1160.114.08021 Boehringer Ingelheim Investigational Site, Dalian

1160.114.08004 Boehringer Ingelheim Investigational Site, Ghuangzhou

1160.114.08006 Boehringer Ingelheim Investigational Site, Ghuangzhou

1160.114.08001 Boehringer Ingelheim Investigational Site, Guangzhou

1160.114.08002 Boehringer Ingelheim Investigational Site, Guangzhou

1160.114.08005 Boehringer Ingelheim Investigational Site, Guangzhou

1160.114.08011 Boehringer Ingelheim Investigational Site, Hangzhou

1160.114.08015 Boehringer Ingelheim Investigational Site, Hangzhou

1160.114.08026 Boehringer Ingelheim Investigational Site, Nanjing

1160.114.08010 Boehringer Ingelheim Investigational Site, Shanghai

1160.114.08012 Boehringer Ingelheim Investigational Site, Shanghai

1160.114.08014 Boehringer Ingelheim Investigational Site, Shanghai

1160.114.08016 Boehringer Ingelheim Investigational Site, Shanghai

1160.114.08027 Boehringer Ingelheim Investigational Site, Shanghai

1160.114.08028 Boehringer Ingelheim Investigational Site, Shenzhen

1160.114.08022 Boehringer Ingelheim Investigational Site, Tianjin

1160.114.08008 Boehringer Ingelheim Investigational Site, Wuhan

1160.114.04002 Boehringer Ingelheim Investigational Site, Krapinske Toplice

1160.114.04001 Boehringer Ingelheim Investigational Site, Opatija

1160.114.04003 Boehringer Ingelheim Investigational Site, Zagreb

1160.114.04004 Boehringer Ingelheim Investigational Site, Zagreb

1160.114.28001 Boehringer Ingelheim Investigational Site, Cairo

1160.114.490201 Boehringer Ingelheim Investigational Site, Berlin

1160.114.490216 Boehringer Ingelheim Investigational Site, Berlin

1160.114.490220 Boehringer Ingelheim Investigational Site, Berlin

1160.114.490217 Boehringer Ingelheim Investigational Site, Dessau

1160.114.490214 Boehringer Ingelheim Investigational Site, Dinslaken

1160.114.490215 Boehringer Ingelheim Investigational Site, Halle

1160.114.490206 Boehringer Ingelheim Investigational Site, Itzehoe

1160.114.490209 Boehringer Ingelheim Investigational Site, Kempen

1160.114.490208 Boehringer Ingelheim Investigational Site, Ludwigsburg

1160.114.490212 Boehringer Ingelheim Investigational Site, Markkleeberg

1160.114.490207 Boehringer Ingelheim Investigational Site, Mühldorf

1160.114.490210 Boehringer Ingelheim Investigational Site, München

1160.114.490202 Boehringer Ingelheim Investigational Site, Northeim

1160.114.490204 Boehringer Ingelheim Investigational Site, Nuremberg

1160.114.490211 Boehringer Ingelheim Investigational Site, Wittenberg

1160.114.07001 Boehringer Ingelheim Investigational Site, Beirut

1160.114.31013 Boehringer Ingelheim Investigational Site, Deventer

1160.114.31008 Boehringer Ingelheim Investigational Site, Enschede

1160.114.31005 Boehringer Ingelheim Investigational Site, Maastricht

1160.114.34012 Boehringer Ingelheim Investigational Site, Barcelona

1160.114.34004 Boehringer Ingelheim Investigational Site, Jaén

1160.114.34010 Boehringer Ingelheim Investigational Site, Madrid

1160.114.34003 Boehringer Ingelheim Investigational Site, Málaga

1160.114.34005 Boehringer Ingelheim Investigational Site, Murcia

1160.114.34013 Boehringer Ingelheim Investigational Site, Sabadell (Barcelona)

1160.114.34011 Boehringer Ingelheim Investigational Site, Santiago de Compostela

1160.114.34001 Boehringer Ingelheim Investigational Site, Seville

1160.114.34006 Boehringer Ingelheim Investigational Site, Seville

1160.114.09004 Boehringer Ingelheim Investigational Site, Adana

1160.114.09001 Boehringer Ingelheim Investigational Site, Ankara

1160.114.09006 Boehringer Ingelheim Investigational Site, Antalya

1160.114.09009 Boehringer Ingelheim Investigational Site, Istanbul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01428765 - GLORIA-AF Registry Program (Phase I) | Biotech Hunter | Biotech Hunter